Nataliya Kotelevets Selected Research

Connective Tissue Growth Factor

1/2011

A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nataliya Kotelevets Research Topics

Disease

4	Carcinoma (Carcinomatosis) 01/2013 - 01/2011
2	Neoplasms (Cancer) 01/2013 - 01/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

2	sphingosine kinaseIBA 01/2012 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2012 - 01/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Connective Tissue Growth FactorIBA 01/2011

Therapy/Procedure

1	Therapeutics 01/2012